Effects of phorbol ester on mitogen and orthovanadate stimulated responses of cultured human fibroblasts

G. A. Jamieson, B. G. Etscheid, Leslie Muldoon, M. L. Villereal

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Mitogenic stimulation of quiescent human fibroblasts (HSWP) with serum or a mixture of growth factors (consisting of vasopressin, bradykinin, EGF, and insulin) stimulates the release of inositol phosphates, mobilization of intracellular Ca, activation of Na/H exchange and subsequent incorporation of [3H]thymidine. We have determined previously that pretreatment with the tumor-promoting phorbol ester 12-0-tetradecanoyl-phorbol-13-acetate (TPA) inhibits mitogen-stimulated Na influx in HSWP cells. We report herein that TPA pretreatment also substantially inhibits the mitogen-stimulated release of inositol phosphates in HSWP cells. Half maximal inhibition of mitogen-stimulated inositol phosphate release occurs at 1-2 nM TPA. Treatment of cells with TPA alone has no effect on inositol phosphate release. The effect of TPA pretreatment on inositol phosphate release induced by individual growth factors has also been determined. Orthovanadate, reported by Cassel et al. (1984) to increase Na/H exchange in A431 cells, has been demonstrated to stimulate both Na influx and inositol phosphate release in HSWP cells. TPA pretreatment also inhibits both orthovanadate-stimulated inositol phosphate release and Na influx. In addition, orthovanadate was determined to increase intracellular Ca activity by mobilizing intracellular calcium stores, as determined with the fluorescent intracellular calcium probe fura-2. TPA pretreatment blocks orthovanadate stimulated mobilization of intracellular Ca stores. It appears clear that in HSWP cells pretreatment of cells with phorbol ester is capable of artificially desensitizing the early cellular responses to mitogenic stimuli (growth factors, orthovanadate) by blocking the signal transduction mechanism involved at a point prior to the release of inositol phosphates. We hypothesize that in HSWP cells the normal desensitization of both inositol phosphate release and Na/H exchange is mediated via activation of protein kinase C subsequent to the stimulus-mediated activation of phospholipase C and release of protein kinase C activator diacylglycerol. However it is interesting to note that TPA-mediated inhibition of these early responses in HSWP cells does not inhibit their ability to be stimulated to incorporate [3H]thymidine. These results are contrasted with those obtained in WI-38 cells. A cell-type in which 1) orthovanadate does not stimulate inositol phosphate release, 2) TPA has minimal or no inhibitory effect on early growth factor induced cellular responses (i.e., inositol phosphate release, intracellular Ca mobilization, activation of Na/H exchange), 3) TPA stimulates Na/H exchanger activity, without activating inositol phosphate release, and 4) TPA promotes (unlike in HSWP cells) the incorporation of [3H]thymidine.

Original languageEnglish (US)
Pages (from-to)220-228
Number of pages9
JournalJournal of Cellular Physiology
Volume134
Issue number2
StatePublished - 1988
Externally publishedYes

Fingerprint

Inositol Phosphates
Vanadates
Phorbol Esters
Fibroblasts
Mitogens
Acetates
Intercellular Signaling Peptides and Proteins
Chemical activation
Thymidine
Ion exchange
Protein Kinase C
phorbol
Cells
Calcium
Signal transduction
Sodium-Hydrogen Antiporter
Fura-2
Diglycerides
Type C Phospholipases
Bradykinin

ASJC Scopus subject areas

  • Cell Biology
  • Clinical Biochemistry
  • Physiology

Cite this

Effects of phorbol ester on mitogen and orthovanadate stimulated responses of cultured human fibroblasts. / Jamieson, G. A.; Etscheid, B. G.; Muldoon, Leslie; Villereal, M. L.

In: Journal of Cellular Physiology, Vol. 134, No. 2, 1988, p. 220-228.

Research output: Contribution to journalArticle

@article{44c9b5938d3449fc9e219c71a72cffda,
title = "Effects of phorbol ester on mitogen and orthovanadate stimulated responses of cultured human fibroblasts",
abstract = "Mitogenic stimulation of quiescent human fibroblasts (HSWP) with serum or a mixture of growth factors (consisting of vasopressin, bradykinin, EGF, and insulin) stimulates the release of inositol phosphates, mobilization of intracellular Ca, activation of Na/H exchange and subsequent incorporation of [3H]thymidine. We have determined previously that pretreatment with the tumor-promoting phorbol ester 12-0-tetradecanoyl-phorbol-13-acetate (TPA) inhibits mitogen-stimulated Na influx in HSWP cells. We report herein that TPA pretreatment also substantially inhibits the mitogen-stimulated release of inositol phosphates in HSWP cells. Half maximal inhibition of mitogen-stimulated inositol phosphate release occurs at 1-2 nM TPA. Treatment of cells with TPA alone has no effect on inositol phosphate release. The effect of TPA pretreatment on inositol phosphate release induced by individual growth factors has also been determined. Orthovanadate, reported by Cassel et al. (1984) to increase Na/H exchange in A431 cells, has been demonstrated to stimulate both Na influx and inositol phosphate release in HSWP cells. TPA pretreatment also inhibits both orthovanadate-stimulated inositol phosphate release and Na influx. In addition, orthovanadate was determined to increase intracellular Ca activity by mobilizing intracellular calcium stores, as determined with the fluorescent intracellular calcium probe fura-2. TPA pretreatment blocks orthovanadate stimulated mobilization of intracellular Ca stores. It appears clear that in HSWP cells pretreatment of cells with phorbol ester is capable of artificially desensitizing the early cellular responses to mitogenic stimuli (growth factors, orthovanadate) by blocking the signal transduction mechanism involved at a point prior to the release of inositol phosphates. We hypothesize that in HSWP cells the normal desensitization of both inositol phosphate release and Na/H exchange is mediated via activation of protein kinase C subsequent to the stimulus-mediated activation of phospholipase C and release of protein kinase C activator diacylglycerol. However it is interesting to note that TPA-mediated inhibition of these early responses in HSWP cells does not inhibit their ability to be stimulated to incorporate [3H]thymidine. These results are contrasted with those obtained in WI-38 cells. A cell-type in which 1) orthovanadate does not stimulate inositol phosphate release, 2) TPA has minimal or no inhibitory effect on early growth factor induced cellular responses (i.e., inositol phosphate release, intracellular Ca mobilization, activation of Na/H exchange), 3) TPA stimulates Na/H exchanger activity, without activating inositol phosphate release, and 4) TPA promotes (unlike in HSWP cells) the incorporation of [3H]thymidine.",
author = "Jamieson, {G. A.} and Etscheid, {B. G.} and Leslie Muldoon and Villereal, {M. L.}",
year = "1988",
language = "English (US)",
volume = "134",
pages = "220--228",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Effects of phorbol ester on mitogen and orthovanadate stimulated responses of cultured human fibroblasts

AU - Jamieson, G. A.

AU - Etscheid, B. G.

AU - Muldoon, Leslie

AU - Villereal, M. L.

PY - 1988

Y1 - 1988

N2 - Mitogenic stimulation of quiescent human fibroblasts (HSWP) with serum or a mixture of growth factors (consisting of vasopressin, bradykinin, EGF, and insulin) stimulates the release of inositol phosphates, mobilization of intracellular Ca, activation of Na/H exchange and subsequent incorporation of [3H]thymidine. We have determined previously that pretreatment with the tumor-promoting phorbol ester 12-0-tetradecanoyl-phorbol-13-acetate (TPA) inhibits mitogen-stimulated Na influx in HSWP cells. We report herein that TPA pretreatment also substantially inhibits the mitogen-stimulated release of inositol phosphates in HSWP cells. Half maximal inhibition of mitogen-stimulated inositol phosphate release occurs at 1-2 nM TPA. Treatment of cells with TPA alone has no effect on inositol phosphate release. The effect of TPA pretreatment on inositol phosphate release induced by individual growth factors has also been determined. Orthovanadate, reported by Cassel et al. (1984) to increase Na/H exchange in A431 cells, has been demonstrated to stimulate both Na influx and inositol phosphate release in HSWP cells. TPA pretreatment also inhibits both orthovanadate-stimulated inositol phosphate release and Na influx. In addition, orthovanadate was determined to increase intracellular Ca activity by mobilizing intracellular calcium stores, as determined with the fluorescent intracellular calcium probe fura-2. TPA pretreatment blocks orthovanadate stimulated mobilization of intracellular Ca stores. It appears clear that in HSWP cells pretreatment of cells with phorbol ester is capable of artificially desensitizing the early cellular responses to mitogenic stimuli (growth factors, orthovanadate) by blocking the signal transduction mechanism involved at a point prior to the release of inositol phosphates. We hypothesize that in HSWP cells the normal desensitization of both inositol phosphate release and Na/H exchange is mediated via activation of protein kinase C subsequent to the stimulus-mediated activation of phospholipase C and release of protein kinase C activator diacylglycerol. However it is interesting to note that TPA-mediated inhibition of these early responses in HSWP cells does not inhibit their ability to be stimulated to incorporate [3H]thymidine. These results are contrasted with those obtained in WI-38 cells. A cell-type in which 1) orthovanadate does not stimulate inositol phosphate release, 2) TPA has minimal or no inhibitory effect on early growth factor induced cellular responses (i.e., inositol phosphate release, intracellular Ca mobilization, activation of Na/H exchange), 3) TPA stimulates Na/H exchanger activity, without activating inositol phosphate release, and 4) TPA promotes (unlike in HSWP cells) the incorporation of [3H]thymidine.

AB - Mitogenic stimulation of quiescent human fibroblasts (HSWP) with serum or a mixture of growth factors (consisting of vasopressin, bradykinin, EGF, and insulin) stimulates the release of inositol phosphates, mobilization of intracellular Ca, activation of Na/H exchange and subsequent incorporation of [3H]thymidine. We have determined previously that pretreatment with the tumor-promoting phorbol ester 12-0-tetradecanoyl-phorbol-13-acetate (TPA) inhibits mitogen-stimulated Na influx in HSWP cells. We report herein that TPA pretreatment also substantially inhibits the mitogen-stimulated release of inositol phosphates in HSWP cells. Half maximal inhibition of mitogen-stimulated inositol phosphate release occurs at 1-2 nM TPA. Treatment of cells with TPA alone has no effect on inositol phosphate release. The effect of TPA pretreatment on inositol phosphate release induced by individual growth factors has also been determined. Orthovanadate, reported by Cassel et al. (1984) to increase Na/H exchange in A431 cells, has been demonstrated to stimulate both Na influx and inositol phosphate release in HSWP cells. TPA pretreatment also inhibits both orthovanadate-stimulated inositol phosphate release and Na influx. In addition, orthovanadate was determined to increase intracellular Ca activity by mobilizing intracellular calcium stores, as determined with the fluorescent intracellular calcium probe fura-2. TPA pretreatment blocks orthovanadate stimulated mobilization of intracellular Ca stores. It appears clear that in HSWP cells pretreatment of cells with phorbol ester is capable of artificially desensitizing the early cellular responses to mitogenic stimuli (growth factors, orthovanadate) by blocking the signal transduction mechanism involved at a point prior to the release of inositol phosphates. We hypothesize that in HSWP cells the normal desensitization of both inositol phosphate release and Na/H exchange is mediated via activation of protein kinase C subsequent to the stimulus-mediated activation of phospholipase C and release of protein kinase C activator diacylglycerol. However it is interesting to note that TPA-mediated inhibition of these early responses in HSWP cells does not inhibit their ability to be stimulated to incorporate [3H]thymidine. These results are contrasted with those obtained in WI-38 cells. A cell-type in which 1) orthovanadate does not stimulate inositol phosphate release, 2) TPA has minimal or no inhibitory effect on early growth factor induced cellular responses (i.e., inositol phosphate release, intracellular Ca mobilization, activation of Na/H exchange), 3) TPA stimulates Na/H exchanger activity, without activating inositol phosphate release, and 4) TPA promotes (unlike in HSWP cells) the incorporation of [3H]thymidine.

UR - http://www.scopus.com/inward/record.url?scp=0023855133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023855133&partnerID=8YFLogxK

M3 - Article

VL - 134

SP - 220

EP - 228

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 2

ER -